摘要
目的观察17β-雌二醇(E2)对成骨细胞胞内游离钙([Ca2+]i)、1,4,5-三磷酸肌醇(IP3)含量及钙调蛋白(CaM)含量的影响。方法以Fluo-3/AM为钙荧光指示剂,采用激光共聚焦显微系统测定细胞内钙荧光值的改变,以反映[Ca2+]i含量的变化。用阳离子交换法测定IP3含量。以测定钙依赖的磷酸二酯酶活性方法测定CaM含量。结果给予0.1、1.0nmol/LE2后50s胞内钙荧光值分别增加4.7和6.1倍,持续80~160s;以100nmol/Lthapsigargin预处理细胞,E2仅使胞内钙荧光值升高1.5倍。加入1.0nmol/LE2,IP3含量在给药后20~30s和60~70s呈双峰升高。同样剂量的E2可使CaM含量增加85.2%。他莫西芬不能阻断E2引起的胞内钙荧光值、IP3及CaM含量升高的作用,而磷脂酶C抑制剂使E2的作用部分或完全抑制。结论E2作用于胞膜引起胞外钙内流,并通过IP3导致[Ca2+]i进一步增加,激活CaM从而调节细胞功能。
Objective To study the effects of 17β estradiol (E 2) on intracellular free calcium ([Ca 2+ ] i), inositol 1,4,5 trisphophate (IP 3) and calmodulin (CaM) in human osteoblast like cell line TE85. Methods Using Fluo 3/AM as fluorescent indicator, the [Ca 2+ ] i was measured by laser confocal microscopy system. The IP 3 content was determined by anion exchange chromatography. CaM content was detected by a high sensitive assay based on stimulation of Ca 2+ dependent phosphodiesterase activity. Results E 2 at dose of 0.1 and 1.0 nmol/L increased fluorescent level by 4.7 and 6.1 times. Pretreatment with thapsigargin (100 nmol/L), the E 2 caused only 1.5 times elevation in fluorescence. E 2 induced a concommitant bi peak increase in IP 3 content. At the presence of E 2 (1.0 nmol/L), the CaM content increased by 85.2%. Tamoxifen did not affect the effect of E 2 on [Ca 2+ ] i, IP 3 and CaM content. But, the inhibitor of phospholipase C (neomycin) and pertusis toxin depressed them partly or completely. Conclusions E 2 regulate bone cells function by way of Ca 2+ /CaM activation.
出处
《中国医学科学院学报》
CAS
CSCD
北大核心
1999年第2期105-110,共6页
Acta Academiae Medicinae Sinicae
基金
国家自然科学基金
关键词
骨质疏松
雌激素
钙调蛋白
三磷酸肌醇
osteoporosis
estrogen
calcium
calmodulin
inositol 1
4
5 trisphophate